IGF1 and Insulin resistance: Reduced skeletal muscle mass also contributes to insulin resistance, increases lipolysis, the release of free fatty acids from adipose tissue, and inhibits the growth hormone (GH)-insulin like growth factor 1 (IGF1) axis (60,61).